Recombinant alpha-1 antitrypsin (Kamada)

N/A

Report date: 2025/03/25 11:25:56

Base Information

Drug NameRecombinant alpha-1 antitrypsin (Kamada)
Drug Alias NameRecombinant AAT
ClassificationBiologics > Protein drugs
Mechanisms of ActionSerine endopeptidase inhibitors
TargetsUpdating
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKamada
China Registration ClassN/A

Develop Information

Active CompaniesKamada
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A